[Clinical aspects of the immunopathogenesis of type I diabetes mellitus].
Scherbaum
W A
WA
D000818:Animals; D001323:Autoantibodies / Q000032:analysis; D001327:Autoimmune Diseases / Q000276:immunology*; D003524:Cyclosporins / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology* / Q000628:therapy; D005455:Fluorescent Antibody Technique; D006681:HLA-D Antigens / Q000032:analysis; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular; D007328:Insulin / Q000276:immunology; D007515:Islets of Langerhans / Q000276:immunology; D051381:Rats; D011913:Rats, Inbred BB
D001323:Autoantibodies; D003524:Cyclosporins; D006681:HLA-D Antigens; D006684:HLA-DR Antigens; D007328:Insulin
Klinische Aspekte zur Immunpathogenese des Diabetes mellitus Typ I.